Carbetocin (Duratocin) Market Report

Japan Carbetocin (Duratocin) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Jun 21, 2020
  • PAGES：146
  • REPORT CODE：GMM571690
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Carbetocin (Duratocin) market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Carbetocin (Duratocin) market. Detailed analysis of key players, along with key growth strategies adopted by Carbetocin (Duratocin) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Bachem AG

    • Beacon Pharmaceuticals Limited

    • BOC Sciences

    • Polypeptide Laboraries France

    By Type:

    • Tablets

    • Injection

    By End-User:

    • Oxytocic

    • Antihemorrhagic

    • Uterotonic

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Carbetocin (Duratocin) Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Carbetocin (Duratocin) Market Size and Growth Rate of Tablets from 2014 to 2026

      • 1.3.2 Japan Carbetocin (Duratocin) Market Size and Growth Rate of Injection from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Oxytocic

      • 1.4.2 Market Size and Growth Rate of Antihemorrhagic

      • 1.4.3 Market Size and Growth Rate of Uterotonic

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Carbetocin (Duratocin) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Carbetocin (Duratocin) by Major Types

      • 3.4.1 Japan Carbetocin (Duratocin) Market Size and Growth Rate of Tablets from 2014 to 2026

      • 3.4.2 Japan Carbetocin (Duratocin) Market Size and Growth Rate of Injection from 2014 to 2026

    4 Segmentation of Carbetocin (Duratocin) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Carbetocin (Duratocin) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Carbetocin (Duratocin) in Oxytocic

      • 4.4.2 Market Size and Growth Rate of Carbetocin (Duratocin) in Antihemorrhagic

      • 4.4.3 Market Size and Growth Rate of Carbetocin (Duratocin) in Uterotonic

    5 Market Analysis by Regions

    • 5.1 Japan Carbetocin (Duratocin) Production Analysis by Regions

    • 5.2 Japan Carbetocin (Duratocin) Consumption Analysis by Regions

    6 Hokkaido Carbetocin (Duratocin) Landscape Analysis

    • 6.1 Hokkaido Carbetocin (Duratocin) Landscape Analysis by Major Types

    • 6.2 Hokkaido Carbetocin (Duratocin) Landscape Analysis by Major End-Users

    7 Tohoku Carbetocin (Duratocin) Landscape Analysis

    • 7.1 Tohoku Carbetocin (Duratocin) Landscape Analysis by Major Types

    • 7.2 Tohoku Carbetocin (Duratocin) Landscape Analysis by Major End-Users

    8 Kanto Carbetocin (Duratocin) Landscape Analysis

    • 8.1 Kanto Carbetocin (Duratocin) Landscape Analysis by Major Types

    • 8.2 Kanto Carbetocin (Duratocin) Landscape Analysis by Major End-Users

    9 Chubu Carbetocin (Duratocin) Landscape Analysis

    • 9.1 Chubu Carbetocin (Duratocin) Landscape Analysis by Major Types

    • 9.2 Chubu Carbetocin (Duratocin) Landscape Analysis by Major End-Users

    10 Kinki Carbetocin (Duratocin) Landscape Analysis

    • 10.1 Kinki Carbetocin (Duratocin) Landscape Analysis by Major Types

    • 10.2 Kinki Carbetocin (Duratocin) Landscape Analysis by Major End-Users

    11 Chugoku Carbetocin (Duratocin) Landscape Analysis

    • 11.1 Chugoku Carbetocin (Duratocin) Landscape Analysis by Major Types

    • 11.2 Chugoku Carbetocin (Duratocin) Landscape Analysis by Major End-Users

    12 Shikoku Carbetocin (Duratocin) Landscape Analysis

    • 12.1 Shikoku Carbetocin (Duratocin) Landscape Analysis by Major Types

    • 12.2 Shikoku Carbetocin (Duratocin) Landscape Analysis by Major End-Users

    13 Kyushu Carbetocin (Duratocin) Landscape Analysis

    • 13.1 Kyushu Carbetocin (Duratocin) Landscape Analysis by Major Types

    • 13.2 Kyushu Carbetocin (Duratocin) Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Bachem AG

      • 14.1.1 Bachem AG Company Profile and Recent Development

      • 14.1.2 Bachem AG Market Performance

      • 14.1.3 Bachem AG Product and Service Introduction

    • 14.2 Beacon Pharmaceuticals Limited

      • 14.2.1 Beacon Pharmaceuticals Limited Company Profile and Recent Development

      • 14.2.2 Beacon Pharmaceuticals Limited Market Performance

      • 14.2.3 Beacon Pharmaceuticals Limited Product and Service Introduction

    • 14.3 BOC Sciences

      • 14.3.1 BOC Sciences Company Profile and Recent Development

      • 14.3.2 BOC Sciences Market Performance

      • 14.3.3 BOC Sciences Product and Service Introduction

    • 14.4 Polypeptide Laboraries France

      • 14.4.1 Polypeptide Laboraries France Company Profile and Recent Development

      • 14.4.2 Polypeptide Laboraries France Market Performance

      • 14.4.3 Polypeptide Laboraries France Product and Service Introduction

     

    The List of Tables and Figures (Totals 113 Figures and 187 Tables)

    • Figure Japan Carbetocin (Duratocin) Market Size and Growth Rate of Tablets from 2014 to 2026

    • Figure Japan Carbetocin (Duratocin) Market Size and Growth Rate of Injection from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Oxytocic

    • Figure Market Size and Growth Rate of Antihemorrhagic

    • Figure Market Size and Growth Rate of Uterotonic

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Carbetocin (Duratocin) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Carbetocin (Duratocin) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Carbetocin (Duratocin)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Carbetocin (Duratocin) by Different Types from 2014 to 2026

    • Table Consumption Share of Carbetocin (Duratocin) by Different Types from 2014 to 2026

    • Figure Japan Carbetocin (Duratocin) Market Size and Growth Rate of Tablets from 2014 to 2026

    • Figure Japan Carbetocin (Duratocin) Market Size and Growth Rate of Injection from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Carbetocin (Duratocin) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Carbetocin (Duratocin) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oxytocic

    • Figure Market Size and Growth Rate of Antihemorrhagic

    • Figure Market Size and Growth Rate of Uterotonic

    • Table Japan Carbetocin (Duratocin) Production by Regions

    • Table Japan Carbetocin (Duratocin) Production Share by Regions

    • Figure Japan Carbetocin (Duratocin) Production Share by Regions in 2014

    • Figure Japan Carbetocin (Duratocin) Production Share by Regions in 2018

    • Figure Japan Carbetocin (Duratocin) Production Share by Regions in 2026

    • Table Japan Carbetocin (Duratocin) Consumption by Regions

    • Table Japan Carbetocin (Duratocin) Consumption Share by Regions

    • Figure Japan Carbetocin (Duratocin) Consumption Share by Regions in 2014

    • Figure Japan Carbetocin (Duratocin) Consumption Share by Regions in 2018

    • Figure Japan Carbetocin (Duratocin) Consumption Share by Regions in 2026

    • Table Hokkaido Carbetocin (Duratocin) Consumption by Types from 2014 to 2026

    • Table Hokkaido Carbetocin (Duratocin) Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Carbetocin (Duratocin) Consumption Share by Types in 2014

    • Figure Hokkaido Carbetocin (Duratocin) Consumption Share by Types in 2018

    • Figure Hokkaido Carbetocin (Duratocin) Consumption Share by Types in 2026

    • Table Hokkaido Carbetocin (Duratocin) Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Carbetocin (Duratocin) Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Carbetocin (Duratocin) Consumption Share by End-Users in 2014

    • Figure Hokkaido Carbetocin (Duratocin) Consumption Share by End-Users in 2018

    • Figure Hokkaido Carbetocin (Duratocin) Consumption Share by End-Users in 2026

    • Table Tohoku Carbetocin (Duratocin) Consumption by Types from 2014 to 2026

    • Table Tohoku Carbetocin (Duratocin) Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Carbetocin (Duratocin) Consumption Share by Types in 2014

    • Figure Tohoku Carbetocin (Duratocin) Consumption Share by Types in 2018

    • Figure Tohoku Carbetocin (Duratocin) Consumption Share by Types in 2026

    • Table Tohoku Carbetocin (Duratocin) Consumption by End-Users from 2014 to 2026

    • Table Tohoku Carbetocin (Duratocin) Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Carbetocin (Duratocin) Consumption Share by End-Users in 2014

    • Figure Tohoku Carbetocin (Duratocin) Consumption Share by End-Users in 2018

    • Figure Tohoku Carbetocin (Duratocin) Consumption Share by End-Users in 2026

    • Table Kanto Carbetocin (Duratocin) Consumption by Types from 2014 to 2026

    • Table Kanto Carbetocin (Duratocin) Consumption Share by Types from 2014 to 2026

    • Figure Kanto Carbetocin (Duratocin) Consumption Share by Types in 2014

    • Figure Kanto Carbetocin (Duratocin) Consumption Share by Types in 2018

    • Figure Kanto Carbetocin (Duratocin) Consumption Share by Types in 2026

    • Table Kanto Carbetocin (Duratocin) Consumption by End-Users from 2014 to 2026

    • Table Kanto Carbetocin (Duratocin) Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Carbetocin (Duratocin) Consumption Share by End-Users in 2014

    • Figure Kanto Carbetocin (Duratocin) Consumption Share by End-Users in 2018

    • Figure Kanto Carbetocin (Duratocin) Consumption Share by End-Users in 2026

    • Table Chubu Carbetocin (Duratocin) Consumption by Types from 2014 to 2026

    • Table Chubu Carbetocin (Duratocin) Consumption Share by Types from 2014 to 2026

    • Figure Chubu Carbetocin (Duratocin) Consumption Share by Types in 2014

    • Figure Chubu Carbetocin (Duratocin) Consumption Share by Types in 2018

    • Figure Chubu Carbetocin (Duratocin) Consumption Share by Types in 2026

    • Table Chubu Carbetocin (Duratocin) Consumption by End-Users from 2014 to 2026

    • Table Chubu Carbetocin (Duratocin) Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Carbetocin (Duratocin) Consumption Share by End-Users in 2014

    • Figure Chubu Carbetocin (Duratocin) Consumption Share by End-Users in 2018

    • Figure Chubu Carbetocin (Duratocin) Consumption Share by End-Users in 2026

    • Table Kinki Carbetocin (Duratocin) Consumption by Types from 2014 to 2026

    • Table Kinki Carbetocin (Duratocin) Consumption Share by Types from 2014 to 2026

    • Figure Kinki Carbetocin (Duratocin) Consumption Share by Types in 2014

    • Figure Kinki Carbetocin (Duratocin) Consumption Share by Types in 2018

    • Figure Kinki Carbetocin (Duratocin) Consumption Share by Types in 2026

    • Table Kinki Carbetocin (Duratocin) Consumption by End-Users from 2014 to 2026

    • Table Kinki Carbetocin (Duratocin) Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Carbetocin (Duratocin) Consumption Share by End-Users in 2014

    • Figure Kinki Carbetocin (Duratocin) Consumption Share by End-Users in 2018

    • Figure Kinki Carbetocin (Duratocin) Consumption Share by End-Users in 2026

    • Table Chugoku Carbetocin (Duratocin) Consumption by Types from 2014 to 2026

    • Table Chugoku Carbetocin (Duratocin) Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Carbetocin (Duratocin) Consumption Share by Types in 2014

    • Figure Chugoku Carbetocin (Duratocin) Consumption Share by Types in 2018

    • Figure Chugoku Carbetocin (Duratocin) Consumption Share by Types in 2026

    • Table Chugoku Carbetocin (Duratocin) Consumption by End-Users from 2014 to 2026

    • Table Chugoku Carbetocin (Duratocin) Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Carbetocin (Duratocin) Consumption Share by End-Users in 2014

    • Figure Chugoku Carbetocin (Duratocin) Consumption Share by End-Users in 2018

    • Figure Chugoku Carbetocin (Duratocin) Consumption Share by End-Users in 2026

    • Table Shikoku Carbetocin (Duratocin) Consumption by Types from 2014 to 2026

    • Table Shikoku Carbetocin (Duratocin) Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Carbetocin (Duratocin) Consumption Share by Types in 2014

    • Figure Shikoku Carbetocin (Duratocin) Consumption Share by Types in 2018

    • Figure Shikoku Carbetocin (Duratocin) Consumption Share by Types in 2026

    • Table Shikoku Carbetocin (Duratocin) Consumption by End-Users from 2014 to 2026

    • Table Shikoku Carbetocin (Duratocin) Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Carbetocin (Duratocin) Consumption Share by End-Users in 2014

    • Figure Shikoku Carbetocin (Duratocin) Consumption Share by End-Users in 2018

    • Figure Shikoku Carbetocin (Duratocin) Consumption Share by End-Users in 2026

    • Table Kyushu Carbetocin (Duratocin) Consumption by Types from 2014 to 2026

    • Table Kyushu Carbetocin (Duratocin) Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Carbetocin (Duratocin) Consumption Share by Types in 2014

    • Figure Kyushu Carbetocin (Duratocin) Consumption Share by Types in 2018

    • Figure Kyushu Carbetocin (Duratocin) Consumption Share by Types in 2026

    • Table Kyushu Carbetocin (Duratocin) Consumption by End-Users from 2014 to 2026

    • Table Kyushu Carbetocin (Duratocin) Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Carbetocin (Duratocin) Consumption Share by End-Users in 2014

    • Figure Kyushu Carbetocin (Duratocin) Consumption Share by End-Users in 2018

    • Figure Kyushu Carbetocin (Duratocin) Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Bachem AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bachem AG

    • Figure Sales and Growth Rate Analysis of Bachem AG

    • Figure Revenue and Market Share Analysis of Bachem AG

    • Table Product and Service Introduction of Bachem AG

    • Table Company Profile and Development Status of Beacon Pharmaceuticals Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beacon Pharmaceuticals Limited

    • Figure Sales and Growth Rate Analysis of Beacon Pharmaceuticals Limited

    • Figure Revenue and Market Share Analysis of Beacon Pharmaceuticals Limited

    • Table Product and Service Introduction of Beacon Pharmaceuticals Limited

    • Table Company Profile and Development Status of BOC Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BOC Sciences

    • Figure Sales and Growth Rate Analysis of BOC Sciences

    • Figure Revenue and Market Share Analysis of BOC Sciences

    • Table Product and Service Introduction of BOC Sciences

    • Table Company Profile and Development Status of Polypeptide Laboraries France

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Polypeptide Laboraries France

    • Figure Sales and Growth Rate Analysis of Polypeptide Laboraries France

    • Figure Revenue and Market Share Analysis of Polypeptide Laboraries France

    • Table Product and Service Introduction of Polypeptide Laboraries France

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US